“Clinical trials are critical” in the battle against the global COVID-19 pandemic, Amy Abernethy, principal deputy commissioner and acting CIO of the U.S. Food and Drug Administration (FDA), told attendees […]
Competency-based and other creative approaches are needed to address the battle for talent in the clinical research workforce.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a study designed to determine whether certain approved therapies or investigational […]
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research—from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of […]
Although it may not be in the cards for many clinical trial sponsors, being able to situate trials at dedicated (or research-only) study sites may provide winning advantages in terms […]